Aster DM Healthcare Limited (ASTERDM) — Financial Results Announcement
Revenue: ₹1,182 CrNet Profit: ₹153 Cr
📢 Key Event
Aster DM Healthcare Q4 FY26 results announced with 18% YoY revenue growth and shareholder approval of merger
🔄 What Changed
Revenue grew 18% YoY to INR 1,182 Cr; Operating EBITDA grew 31% YoY to INR 253 Cr; Normalised PAT grew 45% YoY to INR 153 Cr
🔮 What's Next
Merger expected to close in Q1 FY27 pending regulatory approvals
💡 Investor Takeaway
Strong quarterly growth and merger progress signal scaling momentum and improved profitability for shareholders
Aster DM Healthcare reported robust Q4 FY26 results with revenue up 18% YoY to INR 1,182 Cr and operating EBITDA up 31% YoY to INR 253 Cr, driven by strong performance across core hospital and lab segments. The merger with Quality Care India Limited received overwhelming shareholder approval at 96.68%, positioning the combined entity for scale-up to over 15,500 beds by near term. Management highlighted margin expansion and growth momentum as key drivers for future performance.
📄 View Original Announcement (PDF)
About Aster DM Healthcare Limited (ASTERDM)
Healthcare · Healthcare Services · Listed on NSE
Market Cap: ₹39,048.19 Cr
P/E: 7.1
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.